Mapping susceptibility loci in inflammatory bowel disease: why and how?

被引:10
|
作者
Parkes, M [1 ]
Satsangi, J [1 ]
Jewell, D [1 ]
机构
[1] Radcliffe Infirm, Gastroenterol Unit, Oxford OX2 6HE, England
来源
MOLECULAR MEDICINE TODAY | 1997年 / 3卷 / 12期
基金
英国医学研究理事会;
关键词
D O I
10.1016/S1357-4310(97)01134-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cause sf the inflammatory bowel diseases Crohn's disease and ulcerative colitis is unknown, but epidemiological evidence suggests that it is multifactorial with a strong genetic component. Several genetic loci probably contribute to disease susceptibility, accounting for the complex pattern of of inheritance and heterogeneous clinical manifestations, The combination of candidate gene studies and, more recently, genome-wide searches has resulted in the identification of a number of putative susceptibility loci. With large-scale, fine-mapping studies under way, and accelerating progress in the physical mapping of the human genome, rapid progress is now being made towards the identification of the genes responsible far inflammatory bowel disease.
引用
收藏
页码:546 / 553
页数:8
相关论文
共 50 条
  • [1] Mapping susceptibility loci for inflammatory bowel disease
    Thomas, G
    Hugot, JP
    [J]. IBD AND SALICYLATES - 3, 1998, 20 (01): : 127 - 133
  • [2] Susceptibility loci in inflammatory bowel disease
    Parkes, M
    Satsangi, J
    Lathrop, GM
    Bell, JI
    Jewell, DP
    [J]. LANCET, 1996, 348 (9041): : 1588 - 1588
  • [3] Characteristics of Japanese inflammatory bowel disease susceptibility loci
    Yoshiaki Arimura
    Hiroyuki Isshiki
    Kei Onodera
    Kanna Nagaishi
    Kentaro Yamashita
    Tomoko Sonoda
    Takayuki Matsumoto
    Atsushi Takahashi
    Masakazu Takazoe
    Keiko Yamazaki
    Michiaki Kubo
    Mineko Fujimiya
    Kohzoh Imai
    Yasuhisa Shinomura
    [J]. Journal of Gastroenterology, 2014, 49 : 1217 - 1230
  • [4] Characteristics of Japanese inflammatory bowel disease susceptibility loci
    Arimura, Yoshiaki
    Isshiki, Hiroyuki
    Onodera, Kei
    Nagaishi, Kanna
    Yamashita, Kentaro
    Sonoda, Tomoko
    Matsumoto, Takayuki
    Takahashi, Atsushi
    Takazoe, Masakazu
    Yamazaki, Keiko
    Kubo, Michiaki
    Fujimiya, Mineko
    Imai, Kohzoh
    Shinomura, Yasuhisa
    [J]. JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1217 - 1230
  • [5] Confirmation of three inflammatory bowel disease susceptibility loci in a Chinese cohort
    Lv, Chaolan
    Yang, Xiaoming
    Zhang, Yiyang
    Zhao, Xinmei
    Chen, Zhengyan
    Long, Jinghua
    Zhang, Yingchun
    Zhong, Changqing
    Zhi, Jia
    Yao, Guopeng
    Jiang, Bo
    Zhi, Fachao
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (11) : 1465 - 1472
  • [6] Confirmation of three inflammatory bowel disease susceptibility loci in a Chinese cohort
    Chaolan Lv
    Xiaoming Yang
    Yiyang Zhang
    Xinmei Zhao
    Zhengyan Chen
    Jinghua Long
    Yingchun Zhang
    Changqing Zhong
    Jia Zhi
    Guopeng Yao
    Bo Jiang
    Fachao Zhi
    [J]. International Journal of Colorectal Disease, 2012, 27 : 1465 - 1472
  • [7] Early and late inflammatory bowel disease: why and how are they different?
    Fiocchi, Claudio
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2011, 27 (04) : 317 - 320
  • [8] Fecal biomarkers in inflammatory bowel disease: how, when and why?
    Ministro, Paula
    Martins, Diana
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (04) : 317 - 328
  • [9] Antibiotics and probiotics in inflammatory bowel disease: why, when, and how
    Prantera, Cosimo
    Scribano, Maria Lia
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2009, 25 (04) : 329 - 333
  • [10] Measuring Histologic Activity in Inflammatory Bowel Disease: Why and How
    Pai, Reetesh K.
    Lauwers, Gregory Y.
    Pai, Rish K.
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2022, 29 (01) : 37 - 47